drugset / Trial / NCT04898348
A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis
RandomizedParallel-groupTriple-blindTreatment
Summary
The study is designed to investigate efficacy and safety of KBL697 in patients with mild to moderate active ulcerative colitis. KBL697 has been developed as a potential new treatment for ulcerative colitis.
Timeline
- Start
- 2022-01-14
- Primary completion
- 2023-07-28
- Completion
- 2023-07-28
Outcome
Outcome not reported
Stopped (Enrollment): “No patients recruited”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KBL697 | Unknown | — | — |